اتصال:إيرول زو (السيد)
الهاتف: زائد 86-551-65523315
موبايل / واتس اب: زائد 86 17705606359
س ف:196299583
سكايب:lucytoday@hotmail.com
بريد إلكتروني:sales@homesunshinepharma.com
يضيف:1002، هوانماو بناء رقم 105 ، مينغتشنغ الطريق ، خفى المدينة 230061، الصين
CAS NO: 120685-11-2
Molecular Formula: C35H30N4O4
Molecular Weight: 570.63700
EINECS NO: 848-383-0
MDL NO: NA
Product Description:
Product Name: Midostaurin CAS NO: 120685-11-2
Synonyms:
4'-N-benzoylstaurosporine;
PKC412,9S-(9 ,10 ,11 ,13 )-N-(2,3,10,11,12,13-Hexahydro-10-methoxy-9-methyl-1-oxo-9,13-epoxy-1H,9H-diindolo1,2,3-gh:3',2',1'-lmpyrrolo3,4-j1,7benzodiazonin-11-yl)-N-methylbenzamide;
Cgp 41 251;
Chemical Physical Properties:
Appearance: Tan solid
Assay : Greater than or equal to 99.0 percent
Density: 1.46g/cm3
Refractive Index: 1.76
Storage Condition: Store at 2-8 degree
Solubility: Soluble in DMSO (15 mg/ml), MDC (10 mg/ml), methanol (5 mg/ml), 100 percent ethanol (2.5 mg/ml), and DMF (20 mg/ml).
Safety Information:
Hazard Code: T
Risk Statements: R36/37/38
HS Code: 29329990
Midostaurin (PKC412) is a multi-target protein kinase inhibitor being investigated for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). It is a semi-synthetic derivative of staurosporine, an alkaloid from the bacterium Streptomyces staurosporeus, and is active in patients with mutations of CD135 (FMS-like tyrosine kinase 3 receptor, FLT3).
After successful Phase II clinical trials, a Phase III trial for AML has started in 2008. It is testing midostaurin in combination with daunorubicin and cytarabine. In another trial, the substance has proven ineffective in metastatic melanoma.
If you are interested in our products or have any questions, please feel free to contact us!
Products under patent are offered for R D purpose only. However, the final responsibility lies exclusively with the buyer.
الوسم : midostaurin cas 120685-11-2, manufacturers, suppliers, factory, buy, in stock